p63, cytokeratin 5, and P-cadherin: three molecular markers to distinguish basal phenotype in breast carcinomas

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Virchows Archiv

• Publication date

  2005-07-13

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00428-005-0010-7PMID 16012853
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Basal and luminal breast cancers: basic or luminous? (review).

  2004influential reference
• Hallmarks of 'BRCAness' in sporadic cancers

  2004cited by this paper
• p63 is the molecular switch for initiation of an epithelial stratification program.

  2004cited by this paper
• p63 and the epithelial stem cell: more than status quo?

  2004cited by this paper
• p63: Molecular complexity in development and cancer.

  2004cited by this paper
• Re: Germline BRCA1 Mutations and a Basal Epithelial Phenotype in Breast Cancer

  2004cited by this paper
• Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma

  2004cited by this paper
• Expression of luminal and basal cytokeratins in human breast carcinoma

  2004cited by this paper
• Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer.

  2004cited by this paper
• Distribution of p63, cytokeratins 5/6 and cytokeratin 14 in 51 normal and 400 neoplastic human tissue samples using TARP-4 multi-tumor tissue microarray

  2003cited by this paper
• Repeated observation of breast tumor subtypes in independent gene expression data sets

  2003influential reference
• Novel and Classic Myoepithelial/Stem Cell Markers in Metaplastic Carcinomas of the Breast

  2003cited by this paper
• Evidence of progenitor cells of glandular and myoepithelial cell lineages in the human adult female breast epithelium: a new progenitor (adult stem) cell concept

  2003cited by this paper
• Molecular Classification of Breast Carcinomas Using Tissue Microarrays

  2003cited by this paper
• Breast cancer stem cells revealed

  2003cited by this paper
• Immunohistochemical characteristics defined by tissue microarray of hereditary breast cancer not attributable to BRCA1 or BRCA2 mutations: differences from breast carcinomas arising in BRCA1 and BRCA2 mutation carriers.

  2003cited by this paper
• Common Adult Stem Cells in the Human Breast Give Rise to Glandular and Myoepithelial Cell Lineages: A New Cell Biological Concept

  2002cited by this paper
• Growth factor requirements and basal phenotype of an immortalized mammary epithelial cell line.

  2002cited by this paper
• Tissue Microarrays: A Powerful Tool for High-Throughput Analysis of Clinical Specimens: A Review of the Method With Validation Data

  2002cited by this paper
• Gene expression profiling predicts clinical outcome of breast cancer

  2002cited by this paper
• Re: Skacel M, Skilton B, Pettay JD, Tubbs RR. Tissue microarrays: a powerful tool for high-throughput analysis of clinical specimens. Appl Immunohistochem Molecul Morphol 2002;10:1-6.

  2002cited by this paper
• Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

  2001cited by this paper
• Tissue Microarray Profiling of Cancer Specimens and Cell Lines: Opportunities and Limitations

  2001cited by this paper
• Molecular portraits of human breast tumours

  2000cited by this paper
• Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.

  1998cited by this paper
• Tissue microarrays for high-throughput molecular profiling of tumor specimens

  1998cited by this paper
• Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases

  1997cited by this paper
• Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium.

  1997cited by this paper
• Copyright © American Society for Investigative Pathology Short Communication Expression of Cytokeratins 17 and 5 Identifies a Group of Breast Carcinomas with Poor Clinical Outcome

  year unknowncited by this paper

• Canine mammary tumors as a promising adjunct preclinical model for human breast cancer research: similarities, opportunities, and challenges

  2025cites this paper
• Osteopontin in cancer.

  2024cites this paper
• Altered cytokeratin 5 expression in breast lobular myoepithelial cells

  2023cites this paper
• Evaluation of immunohistopathological profile of tubular and solid canine mammary carcinomas.

  2021cites this paper
• Regulation of breast cancer metastasis signaling by miRNAs

  2020cites this paper
• Differential Expression of E-Cadherin and P-Cadherin in Breast Cancer Molecular Subtypes

  2020cites this paper
• Pets as Sentinels, Forecasters and Promoters of Human Health

  2020cites this paper
• Breast cancer prognosis and P-cadherin expression: systematic review and study-level meta-analysis

  2020cites this paper
• Expression of PD-L1 in primary breast carcinoma and lymph node metastases

  2019cites this paper
• Canine and Feline Spontaneous Mammary Tumours as Models of Human Breast Cancer

  2019cites this paper
• The Molecular Mechanism of Epithelial–Mesenchymal Transition for Breast Carcinogenesis

  2019cites this paper
• ∆Np63/p40 correlates with the location and phenotype of basal/mesenchymal cancer stem‐like cells in human ER+ and HER2+ breast cancers

  2019cites this paper
• Comparative oncology research in Australia: establishing the Australian Veterinary Cancer Biobank to validate canine mammary tumours as a model for human breast cancer

  2018influential citation
• Novel prognostic and predictive microRNA targets for triple‐negative breast cancer

  2018influential citation
• Canine mammary tumors as a model for human disease

  2018cites this paper
• Studying the value of prognostic and predictive biomarkers in breast cancer pathology

  2018cites this paper
• Pathologic Evaluation of Triple-Negative Breast Cancer

  2018cites this paper
• Post-operative radiotherapy is beneficial for T1/T2 triple negative breast cancer patients with four or more positive lymph nodes

  2017cites this paper
• A double dealing tale of p63: an oncogene or a tumor suppressor

  2017cites this paper
• Prognostic value of stromal tumour infiltrating lymphocytes and programmed cell death-ligand 1 expression in breast cancer

  2017cites this paper
• A Survey in the Basal Like Breast Carcinoma Phenotype in North East of Iran

  2017cites this paper
• Integrated diagnostic network construction reveals a 4-gene panel and 5 cancer hallmarks driving breast cancer heterogeneity

  2017cites this paper
• Cell block sensitivity for immunohistochemical detection of cytokeratin 5, oestrogen and progesterone receptors in canine primary mammary carcinoma

  2017cites this paper
• Triple-negative breast cancer in Thai patients: Experience in King Chulalongkorn Memorial Hospital

  2017cites this paper
• Disrupting VEGF-A paracrine and autocrine loops by targeting SHP-1 suppresses triple negative breast cancer metastasis

  2016cites this paper
• Cancer Hallmarks, Biomarkers and Breast Cancer Molecular Subtypes

  2016influential citation
• p63/MT1-MMP axis is required for in situ to invasive transition in basal-like breast cancer

  2016cites this paper
• "Triple negative breast cancer": Translational research and the (re)assembling of diseases in post-genomic medicine.

  2016cites this paper
• Exosome‐encapsulated microRNAs as circulating biomarkers for breast cancer

  2016cites this paper
• Comparative Sensitivities and Specificities of Antibodies to Breast Markers GCDFP-15, Mammaglobin A, and Different Clones of Antibodies to GATA-3: A Study of 338 Tumors Using Whole Sections

  2016cites this paper
• Expresión de citoqueratinas en el cáncer de mama y subtipos tumorales por inmunohistoquímica

  2016influential citation
• Outcomes of Triple-Negative Breast Cancers (TNBC) Compared with Non-TNBC: Does the Survival Vary for All Stages?

  2016cites this paper
• Characterization of P-Cadherin in feline mammary tumours - Association with tumours aggressiveness

  2016cites this paper
• ΔNp63 regulates cell proliferation, differentiation, adhesion, and migration in the BL2 subtype of basal-like breast cancer

  2016influential citation
• Papel prognóstico da expressão de P- caderina no cancro da mama

  2015cites this paper
• CDH3 (Cadherin 3, Type 1, P-Cadherin (Placental))

  2015cites this paper
• Triple-negative Breast Carcinoma: Morphologic and Molecular Subtypes

  2015cites this paper
• Validation of tissue microarray for molecular profiling of canine and feline mammary tumours.

  2015cites this paper
• Clinical performance of diagnostic, prognostic and predictive immunohistochemical biomarkers for hormone receptor-negative breast cancer

  2015cites this paper
• P-cadherin and the journey to cancer metastasis

  2015cites this paper
• Breast-Cancer Subtyping in Clinical Practice: Clinicopathologic Features and Outcomes

  2014cites this paper
• Overexpression of Raf-1 in basal-like carcinoma of the breast: correlation with clinicopathology and prognosis

  2014cites this paper
• Assessment of DNA-damage repair in breast cancer

  2014cites this paper
• Triple-negative Breast Carcinoma in African American and Caucasian Women: Clinicopathology, Immunomarkers, and Outcome

  2014cites this paper
• Estrogen receptor-positive breast cancer molecular signatures and therapeutic potentials (Review).

  2014cites this paper
• We show p 63 regulates growth of esophageal squamous carcinoma cells via the Akt signaling pathway

  2014cites this paper
• Aberrant P-cadherin expression is associated to aggressive feline mammary carcinomas

  2014cites this paper
• Aspectos histopatológicos e imunofenotípicos do carcinoma ductal in situ da mama puro e associado a carcinoma invasor

  2014cites this paper
• p63 regulates growth of esophageal squamous carcinoma cells via the Akt signaling pathway.

  2014cites this paper
• P-cadherin signals through the laminin receptor α6β4 integrin to induce stem cell and invasive properties in basal-like breast cancer cells

  2014cites this paper
• Distinguishing luminal breast cancer subtypes by Ki67, progesterone receptor or TP53 status provides prognostic information

  2014cites this paper
• AUTHOR COPY ONLY Differential sensitivities to lactate transport inhibitors of breast cancer cell lines

  2014cites this paper
• Prognostic and biological significance of proliferation and HER2 expression in the luminal class of breast cancer

  2014cites this paper
• Prognostication of Canine Mammary Carcinomas Based on Histological and Immunohistochemical Subtypes

  2014cites this paper
• Análise da relevância clínica da classificação histológica dos carcinomas de mama de tipos lobular e ductal e sua relação com a classificação molecular

  2014cites this paper
• Differential sensitivities to lactate transport inhibitors of breast cancer cell lines.

  2013cites this paper
• A survey of immunohistochemical biomarkers for basal-like breast cancer against a gene expression profile gold standard

  2013cites this paper
• Clinicopathological significance of ERCC1 expression in breast cancer.

  2013cites this paper
• p16 expression correlates with basal-like triple-negative breast carcinoma

  2013cites this paper
• Regulation of CDH3/P-CADHERIN in Normal and Tumour Epithelial Tissues

  2013cites this paper
• Characterization of specific p63 and p63-N-terminal isoform antibodies and their application for immunohistochemistry

  2013cites this paper
• Correlation of tumor-infiltrating lymphocytes to histopathological features and molecular phenotypes in canine mammary carcinoma: A morphologic and immunohistochemical morphometric study.

  2013cites this paper
• Biology and Treatment of Basal-Like Breast Cancer

  2013cites this paper
• Identification of triple-negative and basal-like canine mammary carcinomas using four basal markers.

  2013influential citation
• Molecular phenotype in mammary tumours of queens: correlation between primary tumour and lymph node metastasis.

  2013cites this paper
• Comedo-DCIS is a precursor lesion for basal-like breast carcinoma: identification of a novel p63/Her2/neu expressing subgroup

  2013cites this paper
• A search for miRNAs that regulates the expression of the atypical kinases

  2013cites this paper
• A simple immunohistochemical panel comprising 2 conventional markers, Ki67 and p53, is a powerful tool for predicting patient outcome in luminal-type breast cancer

  2013cites this paper
• Salivary Gland–like Tumors of the Breast Express Basal-type Immunohistochemical Markers

  2013influential citation
• Immunohistochemical profile of high-grade ductal carcinoma in situ of the breast

  2013cites this paper
• P-cadherin and vimentin are useful basal markers in breast cancers.

  2013cites this paper
• Molecular insights on basal-like breast cancer

  2012cites this paper
• P‐Cadherin Is Coexpressed with CD44 and CD49f and Mediates Stem Cell Properties in Basal‐like Breast Cancer

  2012cites this paper
• P-cadherin expression and basal-like subtype in breast cancers

  2012cites this paper
• A comprehensive morphological study for basal-like breast carcinomas with comparison to nonbasal-like carcinomas

  2012cites this paper
• Generation of an oncolytic adenovirus vector combining three cancer targeting strategies and characterization of a new preclinical model for breast cancer virotherapy

  2012cites this paper
• Mechanistic Investigation of Tolfenamic Acid, Betulinic Acid, and Aspirin in Anti-Cancer Therapy

  2012cites this paper
• Immunochemistry for oestrogen receptor, progesterone receptor and HER2 on cell blocks in primary breast carcinoma

  2012influential citation
• Relationships Between Immunophenotype, Ki-67 Index, Microvascular Density, Ep-CAM/P-cadherin, and MMP-2 Expression in Early-stage Invasive Ductal Breast Cancer

  2012cites this paper
• Epithelial E- and P-cadherins: role and clinical significance in cancer.

  2012cites this paper
• Local Recurrence and Distant Metastases after Breast Conservation Treatment in Women with Triple Negative Breast Cancer Subtype

  2012cites this paper
• A MicroRNA196a2* and TP63 Circuit Regulated by Estrogen Receptor-α and ERK2 that Controls Breast Cancer Proliferation and Invasiveness Properties

  2012cites this paper
• Expressão de marcadores de células-tronco em carcinoma espontaneo de mama em cadelas e sua correlação com o grau de agressividade nos diferentes subtipos de tumores

  2012cites this paper
• Keratin expression in breast cancers

  2012cites this paper
• Reappraisal of immunohistochemical profiling of special histological types of breast carcinomas: a study of 121 cases of eight different subtypes

  2012influential citation
• Serological Analysis of SEREX-Defined Medullary Breast Carcinoma-Associated Antigens

  2012cites this paper
• Inference of the Basal Epithelial Phenotype in Breast Carcinoma from Differential Marker Expression, Using Tissue Microarrays in Triple Negative Breast Cancer and Women Younger than 35

  2012cites this paper
• Immunohistochemical characterization of molecular subtypes of invasive breast cancer: a study from North India

  2012cites this paper
• Molecular classification of breast carcinomas with particular emphasis on “basal‐like” carcinoma: A critical review

  2012cites this paper
• P-cadherin as prognostic factor for loco-regional relapse in breast cancer.

  2012cites this paper
• Clinical significance of basal-like breast cancer in Chinese women in Heilongjiang province.

  2012cites this paper
• Nerve growth factor receptor (NGFR): a potential marker for specific molecular subtypes of breast cancer

  2012cites this paper
• Role of p63 in Development, Tumorigenesis and Cancer Progression

  2012cites this paper
• Negative/low HER2 expression alone or combined with E-cadherin positivity is predictive of better prognosis in patients with breast carcinoma.

  2012cites this paper
• Cadherin Cell Adhesion System in Canine Mammary Cancer: A Review

  2012cites this paper
• PERFIL INMUNOHISTOQUÍMICO Y LA CARACTERIZACIÓN MOLECULAR DEL CARCINOMA DE MAMA EN UNA POBLACIÓN VENEZOLANA

  2012influential citation
• ROLE OF RECEPTORS IN BREAST CANCER

  2012cites this paper
• A review of the biological and clinical characteristics of luminal‐like oestrogen receptor‐positive breast cancer

  2012influential citation
• Basal Phenotype Breast Cancer: Implications for Treatment and Prognosis

  2011cites this paper
• The DeltaNp63 proteins are key allies of BRCA1 in the prevention of basal-like breast cancer.

  2011cites this paper